Selenium
Updated October 7, 2026 · By Marcus Reid
The Short Answer
Selenium is an essential trace mineral with antioxidant properties studied extensively for prostate health. The Nutritional Prevention of Cancer (NPC) Trial found that 200 mcg daily reduced prostate cancer incidence in men with low baseline selenium. However, larger subsequent trials (SELECT, SWOG S9917) did not replicate this finding. Current evidence suggests selenium's benefit may be limited to men who are selenium-deficient. The RDA is 55 mcg; most prostate formulas provide 50–200 mcg.
What is Selenium?
Selenium is an essential trace mineral required for the production of selenoproteins, a family of enzymes with antioxidant, anti-inflammatory, and thyroid-regulating functions. Dietary sources include Brazil nuts, seafood, organ meats, and grains (depending on soil selenium content). In supplement form, selenium is available as selenomethionine, selenium gluconate, sodium selenite, and high-selenium yeast. The different forms vary in bioavailability and clinical trial representation.
How it works
Selenium's relevance to prostate health centers on its role in the antioxidant enzyme system. Selenoproteins — particularly glutathione peroxidases and thioredoxin reductases — neutralize reactive oxygen species (ROS) in prostate tissue. Chronic oxidative stress in the prostate is associated with age-related cellular changes, and adequate selenium status supports the enzymatic defense against this process. Additionally, selenium has been studied for its potential to modulate apoptotic pathways in prostate cells and influence androgen receptor signaling. However, these mechanisms do not extend to disease treatment claims.
What the evidence says
Selenium has been the subject of several large-scale clinical trials for prostate health, producing mixed and sometimes contradictory results. The evidence suggests that selenium supplementation may benefit individuals with low baseline selenium status but does not provide a universal protective effect.
- The NPC Trial found 200 mcg/day selenium reduced prostate cancer incidence in men with low baseline selenium. — The Nutritional Prevention of Cancer Trial supplemented participants with 200 mcg/day of high-selenium yeast. Analysis of the complete treatment period showed significantly reduced prostate cancer incidence, but the protective effect was limited to men in the lowest two tertiles of baseline plasma selenium (< 123 ng/mL). (Duffield-Lillico et al. (2003), BJU International)
- The SWOG S9917 Phase III trial found no benefit of selenium at 200 mcg/day for prostate cancer prevention. — A Phase III randomized, placebo-controlled trial of 200 mcg/day selenium in men with high-grade prostatic intraepithelial neoplasia found three-year cancer rates of 36.6% (placebo) versus 35.6% (selenium) — no significant difference. (Marshall et al. (2011), Cancer Prevention Research)
- Selenium supplementation at 200 mcg/day did not reduce prostate cancer risk in the SELECT trial. — The Selenium and Vitamin E Cancer Prevention Trial randomized 35,533 men to selenium (200 mcg/day), vitamin E, both, or placebo. After 7+ years of follow-up, selenium did not reduce prostate cancer incidence. Vitamin E was associated with a 17% increased risk. The trial was terminated early for lack of benefit. (2009, JAMA (PMID 19066370))
Effective dosage
The RDA for selenium is 55 mcg daily for adults. The NPC Trial used 200 mcg daily of high-selenium yeast and found reduced prostate cancer incidence in men with baseline selenium levels below 123 ng/mL. The subsequent SELECT trial also used 200 mcg daily (as selenomethionine) but found no benefit and a nonsignificant trend toward increased diabetes risk.
Prostate support formulas typically provide 50–200 mcg per serving. The tolerable upper intake level (UL) is 400 mcg daily — excessive selenium intake can cause selenosis (hair loss, nail brittleness, gastrointestinal distress, neurological symptoms). ProstaFense provides 70 mcg (125% DV), a moderate and safe amount.
Safety and interactions
Selenium is safe at recommended doses (55–200 mcg daily) for most adults. The tolerable upper intake level is 400 mcg daily. Chronic intake above 400 mcg can cause selenosis, characterized by garlic breath, hair loss, brittle nails, fatigue, and gastrointestinal issues.
The SELECT trial raised a concern about a possible link between selenium supplementation and type 2 diabetes risk, though this finding was not statistically significant. Individuals already consuming adequate selenium through diet (common in the United States) may not benefit from additional supplementation and should avoid stacking selenium from multiple supplement sources.
Frequently Asked Questions
Does selenium help with prostate health?
Early trial data (the NPC Trial) suggested that 200 mcg daily of selenium could reduce prostate cancer incidence in men with low baseline selenium. However, larger subsequent trials (SELECT, SWOG S9917) did not confirm this benefit. Current evidence suggests selenium's value is primarily as a general antioxidant co-factor, with prostate-specific benefits limited to men who are selenium-deficient.
How much selenium is safe to take daily?
The RDA is 55 mcg and the tolerable upper intake level is 400 mcg daily. Most prostate formulas provide 50–200 mcg. If you take multiple supplements, check for selenium overlap to avoid exceeding 400 mcg total. Chronic excess causes selenosis (hair loss, nail problems, GI distress).
Should I take selenium for prostate health?
The landmark SELECT trial (35,533 men) found no prostate benefit from selenium supplementation at 200 mcg/day. Selenium adequacy matters — deficiency impairs antioxidant defense — but most North American diets already provide sufficient selenium. A single Brazil nut daily provides approximately 70–90 mcg. If you suspect deficiency, a serum selenium test can guide supplementation.